11/9/2026 3:04:23 PM Broader Bolar – Same Battleground? By Wendela Hårdemark Eleanor Root Sophie Vo The EU Pharma Package: Broader Bolar – Same Battleground? The Bolar exemption (“Bolar 1.0”) determines the extent to which preparatory...
11/4/2026 4:31:32 PM What does the 2026 Autumn Budget mean for life sciences businesses? By Heidi Hurdle Charlotte Getz The UK government delivered its Autumn Budget on 28 October 2026. At first sight, the Budget contains relatively few announcements...
10/30/2026 2:07:21 PM Beyond Brexit: CE marking gets a long-term future for medical devices By Pieter Erasmus Moona Malik Serena Gordon The Government’s consultation confirms that CE recognition for medical devices is here to stay, but the future role UKCA-marking will...
10/27/2026 9:48:28 AM Key features of the new 2026 CEPS framework agreement: security of supply, medicinal product pricing and intellectual property By Marylis Clerc Johanna Harelimana Manon Perret On 28 September 2026, the CEPS (French Pricing Authority) entered into a new framework agreement, with the LEEM (the leading trade...
10/9/2026 2:04:36 PM EU Pharmaceutical Package Moves Closer to Adoption: Focus on Antimicrobial Resistance By Nour Saab Johanna Harelimana This article is part of a series on the final agreement reached regarding the pharmaceutical package, which is currently awaiting formal...
10/6/2026 12:22:15 PM The UK’s blueprint for regulating AI in healthcare: what you need to know By Pieter Erasmus Serena Gordon Moona Malik The National Commission into the Regulation of AI in Healthcare, established by the Medicines and Healthcare products Regulatory Agency...
8/12/2026 12:23:21 PM AI Scribes in the NHS: From Compliance Questions to Formal Investigation By Pieter Erasmus Moona Malik Following our recent BioTalk article, Ambient Scribing in the NHS: A Compliance Framework Suppliers Cannot Ignore (30 July 2026), a...
8/10/2026 11:05:42 AM The EU Pharma Package: New Architecture for Regulatory Exclusivities By Christian Lindenthal Annelie Säurig After more than two years of intense legislative debate, the EU institutions reached an agreement on the EU Pharma Package – the most...
7/27/2026 8:51:31 AM Is Your Healthcare AI Tool a Medical Device? What the CJEU's Latest MDR Decision Means for Digital Health Companies By Christian Lindenthal Clarissa Junge-Gierse Annelie Säurig The Court of Justice of the European Union (CJEU, 2 July 2026, Case C-427/24, Diagramm Halbach) has recently issued an important judgment...
7/10/2026 9:07:28 AM EU Pharma Package: transitional provisions By Marc Martens Maarten Princen After more than two decades, the legal architecture governing medicinal products in the European Union is being fundamentally rebuilt....
6/9/2026 2:14:52 PM Valuing Innovation Under Uncertainty: Damages and Remedies in Life Sciences Arbitration By Flore Poloni Lucile Mourey Your pipeline asset took years to develop. The partnership that was supposed to bring it to market has broken down. Now a tribunal needs...
6/3/2026 12:38:29 PM UK court grants landmark website blocking injunction against suppliers of counterfeit prescription-only medicines By Heidi Hurdle A UK judge has for the first time granted a website blocking injunction targeting counterfeit and unlicensed prescription-only medicines....
4/9/2026 2:07:26 PM New US Tariffs on Pharmaceutical Imports: What Life Sciences Companies Need to Know By Phoebe Greybanks The United States has introduced sweeping new tariffs targeting patented pharmaceutical products and their ingredients, with duties set...
4/9/2026 9:58:05 AM France to impose new tax on pharmaceutical companies “unduly delaying” generic entry through patent filing and litigation strategies By Anne-Charlotte Le Bihan Marylis Clerc Following our recent coverage of the new US tariffs on pharmaceutical imports, it is worth noting that Europe is also seeing significant...
1/30/2026 11:21:12 AM EDPB Reconsiders Anonymisation and Pseudonymisation After SRB: What Life Sciences Organisations Need to Know By Wilfred Steenbruggen 1. Introduction On 12 December 2025, the European Data Protection Board (EDPB) hosted a focused stakeholder event to gather input for...
1/15/2026 1:56:33 PM Understanding the impact of the European Accessibility Act on Medical Devices By Kelly Mackey Deirdre Kilroy Understanding the impact of the European Accessibility Act on Medical Devices The European Accessibility Act (Directive (EU) 2019/882)...